CMPI Board of Directors
The CMPI Board of Directors is comprised of some of the nation’s leaders in academic medical research, clinical practice, health care delivery, patient advocacy, innovation leadership and science reporting. The board will be involved in helping CMPI reaching a broader group of stakeholders in their respective communities and in shaping CMPI programs in the future.
|
Bruce Booth
|
Principal,
Atlas Venture
|
|
Bruce Brandfon
|
Publisher,
Scientific American
|
|
Fred Goodwin, M.D.
|
Professor of Psychiatry,
The George Washington University Medical Center.
|
|
Dennis Johnson
|
Vice President,
Policy and External Affairs at The Children’s Health Fund
|
|
Suzanne Pattee, J.D.
|
Vice president,
Public Policy and Patient Affairs for the Cystic Fibrosis
|
|
Steven Sammut
|
Lecturer,
Wharton School, the Law School and the School of Engineering and Applied Science of the University of Pennsylvania
|
|
Michael Tew
|
Principal
Sand Hill Research Partners
|
|
Mark Thornton, M.D., Ph.D.
|
Chairman and President,
Sarcoma Foundation of America
|
|
Michael Weber, M.D.
|
Associate Dean and Professor of Medicine
SUNY Downstate College of Medicine
Brooklyn, New York
|
